Jeffrey Simard

Jeffrey Simard

Company: C4 Therapeutics

Job title: Associate Director, Cell Pharmacology


High-Throughput Quantitative Assay Technologies for Accelerating the Discovery & Optimization of Targeted Protein Degradation Therapeutics 12:00 pm

*Remote Presentation* Review of emerging technologies for higher throughput cellular assays amenable for TPD Advantages and disadvantages of fluorescent protein fusions and reporter tags, flow cytometry, TR-FRET and split luciferase systems for monitoring target degradation General strategies to accelerate targeted protein degradation drug discovery effortsRead more

day: Pre-Conference Focus Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.